-
The impact of the COVID-19 pandemic on renal cancer care
Yildirim, H., Bins, A. D., van den Hurk, C., van Moorselaar, R. J. A., van Oijen, M. G. H., Bex, A., Zondervan, P. J. & Aben, K. K. H., 1 Dec 2024, In: World Journal of Urology. 42, 1, 231.Research output: Contribution to journal › Article › Academic › peer-review
-
The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for ‘Trial within Cohorts’ study designs
Yildirim, H., Widdershoven, C. V., Aarts, M. J., Bex, A., Bloemendal, H. J., Bochove-Overgaauw, D. M., Hamberg, P., Herbschleb, K. H., van der Hulle, T., Lagerveld, B. W., van Oijen, M. G., Oosting, S. F., van Thienen, J. V., van der Veldt, A. A., Westgeest, H. M., Zeijdner, E. E., Aben, K. K., van den Hurk, C., Zondervan, P. J. & Bins, A. D., 1 Dec 2023, In: BMC Cancer. 23, 1, 648.Research output: Contribution to journal › Article › Academic › peer-review
-
Changes to Primary End Points in Randomized Clinical Trials on Immune Checkpoint Inhibitors in Urothelial, Renal Cell, and Lung Cancers: A Systematic Review
Yildirim, H., 1 Aug 2023, In: JAMA oncology. 9, 8, p. 1144-1147Research output: Contribution to journal › Article › Academic › peer-review
- All publications
